In its complaint, BMS alleges that HHS' Health Resources and Services Administration (HRSA), which has responsibility for ...
The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides ...
Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.
Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...
Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...
The 340B program has received its share of criticisms, largely due to the lack of transparency into covered entities that receive the discounts from drug manufacturers.
The federal 340B Drug Pricing Program — a noble idea first enacted in 1992 — needs to be brought back into the shop for ...
In its zeal to shrink the federal government, will the coming Trump administration disrupt a discount drug program that underpins the rural hospitals serving the communities that gave him their ...
The record-breaking rate is a testament to the ability of Ryan White providers who also use savings from the 340B Drug Pricing Program to link people to care and then ensure they remain in care on the ...
Bristol Myers Squibb is the latest pharma company to sue the federal government over its rejection of a proposed new model ...
Bristol Myers Squibb Co. is challenging a federal health agency for denying its plan to implement a rebate model for its ...
Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback